These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 30833428)

  • 1. Generating Robust and Informative Nonclinical
    Bulitta JB; Hope WW; Eakin AE; Guina T; Tam VH; Louie A; Drusano GL; Hoover JL
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents.
    Rizk ML; Bhavnani SM; Drusano G; Dane A; Eakin AE; Guina T; Jang SH; Tomayko JF; Wang J; Zhuang L; Lodise TP
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics-pharmacodynamics, computer decision support technologies, and antimicrobial stewardship: the compass and rudder.
    Owens RC; Bulik CC; Andes DR
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):371-382. PubMed ID: 29776710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
    Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL
    Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives.
    de Velde F; Mouton JW; de Winter BCM; van Gelder T; Koch BCP
    Pharmacol Res; 2018 Aug; 134():280-288. PubMed ID: 30033398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents.
    Asín-Prieto E; Rodríguez-Gascón A; Isla A
    J Infect Chemother; 2015 May; 21(5):319-29. PubMed ID: 25737147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools to define the relevance of PK/PD parameters to the efficacy, toxicity and emergence of resistance of antimicrobials.
    Hickey E
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):49-52. PubMed ID: 17265741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo infection models in the pre-clinical pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents.
    Andes DR; Lepak AJ
    Curr Opin Pharmacol; 2017 Oct; 36():94-99. PubMed ID: 28964956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.
    Onufrak NJ; Forrest A; Gonzalez D
    Clin Ther; 2016 Sep; 38(9):1930-47. PubMed ID: 27449411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics/Pharmacodynamics models of veterinary antimicrobial agents.
    Luo W; Chen D; Wu M; Li Z; Tao Y; Liu Q; Pan Y; Qu W; Yuan Z; Xie S
    J Vet Sci; 2019 Sep; 20(5):e40. PubMed ID: 31565887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents.
    Zhao M; Lepak AJ; Andes DR
    Bioorg Med Chem; 2016 Dec; 24(24):6390-6400. PubMed ID: 27887963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: the goals of antimicrobial therapy.
    Song JH
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S1-4. PubMed ID: 12839701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?
    Barker CI; Standing JF; Turner MA; McElnay JC; Sharland M
    Curr Opin Infect Dis; 2012 Jun; 25(3):235-42. PubMed ID: 22517604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.